KQED Radio
KQED Newssee more
Latest Newscasts:KQEDNPR
Player Sponsored By
upper waypoint

Affordable California-Branded Insulin to Enter National Market

Save ArticleSave Article
Failed to save article

Please try again

 (George Frey via Getty Images)

California Governor Gavin Newsom announced on Saturday a 10-year partnership with nonprofit drug company Civica Rx to manufacture the state’s own supply of insulin. Part of the state’s new CalRx program, the move is only the first step in California’s ambitious plan to produce more affordable generic prescription drugs — like overdose reversal medication naloxone — and make them available on the national market. We’ll talk about CalRx and how it could help address the nation’s drug affordability crisis.


Angela Hart, senior correspondent covering health care politics and policy in California and the West, Kaiser Health News and California Healthline

Kevin Wren, patient advocate and volunteer, California #insulin4all

Robin Feldman, professor and director of the Center for Innovation, UC Law; author of “Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices”


lower waypoint
next waypoint